Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
Public ClinicalTrials.gov record NCT07632001. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Controlled Multicenter Trial, Examining the Effect of Miro3D Wound Matrix on the Rate of Complete Wound Closure of Chronic Diabetic Foot Ulcers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to evaluate whether the Miro3D Wound Matrix, when used in addition to standard of care, improves healing outcomes in patients with chronic diabetic foot ulcers. Diabetic foot ulcers are a common and serious complication of diabetes and may be difficult to heal despite appropriate treatment. Standard of care typically includes regular wound cleaning, debridement (removal of dead tissue), offloading (reducing pressure on the wound), and moisture-balancing dressings. However, some wounds fail to heal with standard treatment alone. Miro3D Wound Matrix is a three-dimensional, acellular scaffold derived from porcine tissue that is intended to support wound healing. This study will compare outcomes in patients treated with Miro3D plus standard of care versus standard of care alone. Approximately 180 adult subjects with non-healing diabetic foot ulcers will be enrolled at multiple clinical sites in the United States. After a two-week screening period, eligible participants will be randomly assigned to receive either Miro3D in addition to standard of care or standard of care alone. Subjects will be followed for up to 12 weeks with weekly clinic visits. The primary objective of the study is to determine whether treatment with Miro3D increases the rate of complete wound closure and improves reduction in wound size compared to standard of care alone. Safety will also be evaluated by monitoring adverse events throughout the study.
Study identification
- NCT ID
- NCT07632001
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 180 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 14, 2026
- Primary completion
- Feb 28, 2027
- Completion
- Apr 30, 2027
- Last update posted
- Aug 12, 2026
2026 – 2027
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Foot Care | Phoenix | Arizona | 85032 | Recruiting |
| West Boca Center for Wound Healing | Coconut Creek | Florida | 33073 | Not yet recruiting |
| Solutions Medical Research | Coral Gables | Florida | 33134 | Recruiting |
| Doctors Research Network | Miami | Florida | 33156 | Not yet recruiting |
| Barry University | Tamarac | Florida | 33321 | Recruiting |
| Clinical Trials of New England | Hyde Park | Massachusetts | 02136 | Not yet recruiting |
| Mercy Hyperbaric and Wound Care | St Louis | Missouri | 63128 | Not yet recruiting |
| St. Louis Foot & Ankle | St Louis | Missouri | 63128 | Not yet recruiting |
| Christian Hospital Wound Center | St Louis | Missouri | 63136 | Not yet recruiting |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | Not yet recruiting |
| ABC Podiatry | Columbus | Ohio | 43213 | Recruiting |
| Dynamic Wound Care | Oklahoma City | Oklahoma | 73159 | Not yet recruiting |
| Caring Foot and Ankle Specialists | Houston | Texas | 77035 | Recruiting |
| Vital Heart and Vein | Humble | Texas | 77338 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07632001, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07632001 live on ClinicalTrials.gov.